JULIO BELARMINO
BOBES GARCIA
Researcher to 2022
Vicente
Balanzá Martínez
Publications by the researcher in collaboration with Vicente Balanzá Martínez (19)
2021
-
Chronic obstructive pulmonary disease in severe mental illness: A timely diagnosis to advance the process of quitting smoking
European psychiatry : the journal of the Association of European Psychiatrists, Vol. 64, Núm. 1, pp. e22
-
Impact of previous tobacco use with or without cannabis on first psychotic experiences in patients with first-episode psychosis
Schizophrenia Research, Vol. 236, pp. 19-28
-
Spanish validation of the Empirically Developed Clinical Staging Model (EmDe-5) for patients with bipolar disorder
Revista de Psiquiatria y Salud Mental
-
The usefulness of Olanzapine plasma concentrations in monitoring treatment efficacy and metabolic disturbances in first-episode psychosis
Psychopharmacology, Vol. 238, Núm. 3, pp. 665-676
2019
-
"readiness to Change" Predicts Efficacy of Reduction among Smokers with Severe Mental Illness
European Addiction Research, Vol. 25, Núm. 5, pp. 256-262
2018
-
Factors associated with poor functional outcome in bipolar disorder: sociodemographic, clinical, and neurocognitive variables
Acta Psychiatrica Scandinavica, Vol. 138, Núm. 2, pp. 145-154
-
Is cognitive impairment associated with antipsychotic dose and anticholinergic equivalent loads in first-episode psychosis?
Psychological Medicine, Vol. 48, Núm. 13, pp. 2247-2256
2017
-
Do patients with bipolar disorder and subsyndromal symptoms benefit from functional remediation? A 12-month follow-up study
European Neuropsychopharmacology, Vol. 27, Núm. 4, pp. 350-359
-
Persistent negative symptoms in first-episode psychosis: Early cognitive and social functioning correlates and differences between early and adult onset
Journal of Clinical Psychiatry, Vol. 78, Núm. 9, pp. 1414-1422
-
The course of negative symptoms in first-episode schizophrenia and its predictors: A prospective two-year follow-up study
Schizophrenia Research, Vol. 189, pp. 84-90
2016
-
A Pharmacovigilance Study in First Episode of Psychosis: Psychopharmacological Interventions and Safety Profiles in the PEPs Project
International Journal of Neuropsychopharmacology, Vol. 19, Núm. 4
-
Cognitive reserve in bipolar disorder: Relation to cognition, psychosocial functioning and quality of life
Acta Psychiatrica Scandinavica, Vol. 133, Núm. 5, pp. 386-398
-
Effects of functional remediation on neurocognitively impaired bipolar patients: Enhancement of verbal memory
Psychological Medicine, Vol. 46, Núm. 2, pp. 291-301
-
Functional remediation in bipolar disorder: 1-year follow-up of neurocognitive and functional outcome
British Journal of Psychiatry, Vol. 208, Núm. 1, pp. 87-93
-
Opposite cannabis-cognition associations in psychotic patients depending on family history
PLoS ONE, Vol. 11, Núm. 8
2015
-
Functional remediation for patients with bipolar II disorder: Improvement of functioning and subsyndromal symptoms
European Neuropsychopharmacology, Vol. 25, Núm. 2, pp. 257-264
-
Premorbid adjustment and clinical correlates of cognitive impairment in first-episode psychosis: The PEPsCog Study
Schizophrenia Research, Vol. 164, Núm. 1-3, pp. 65-73
2014
-
Verbal memory as a mediator in the relationship between subthreshold depressive symptoms and functional outcome in bipolar disorder
Journal of Affective Disorders, Vol. 160, pp. 50-54
2013
-
Efficacy of functional remediation in bipolar disorder: A multicenter randomized controlled study
American Journal of Psychiatry, Vol. 170, Núm. 8, pp. 852-859